HENGRUI PHARMA (01276) has issued an announcement regarding the upcoming expiration of its Ninth Board of Directors' term. In accordance with the company's Articles of Association and relevant regulatory requirements, an election will be held to form the Tenth Board of Directors. The Tenth Board will consist of eleven directors, including six executive directors (one of whom is a staff representative director), one non-executive director, and four independent non-executive directors.
Following the recommendation of the Board Nomination Committee, a board meeting was convened on March 2, 2026, proposing the re-election of Mr. Sun Piaoyang, Mr. Dai Hongbin, Ms. Feng Ji, Mr. Zhang Lianshan, and Mr. Jiang Ningjun as executive directors of the Tenth Board. It was also proposed to re-elect Ms. Guo Congzhao as a non-executive director, and to re-elect Mr. Zeng Qingsheng, Mr. Sun Jinyun, and Mr. Zhou Jien as independent non-executive directors (collectively referred to as the "Re-elected Directors").
Mr. Dong Jiahong, an independent non-executive director, will not stand for re-election to the Tenth Board due to the new board election. Consequently, he will retire from his positions as independent non-executive director, Chairman of the Nomination Committee, member of the Board Audit Committee, and member of the Board Strategy Committee, with all changes effective upon the conclusion of the Annual General Meeting. Following his retirement, Mr. Dong will no longer hold any position within the company.
Based on the Nomination Committee's recommendation, the Board has proposed appointing Mr. Lou Liguang (collectively referred to with the Re-elected Directors as the "Proposed Directors") as an independent non-executive director.
Additionally, on March 2, 2026, the company held a Staff Congress, where Mr. Sun Jieping was re-elected as the staff representative director through the company's staff representative election process. He will join the other elected directors to form the Tenth Board of Directors. His term will commence on the date of the Annual General Meeting and will last until the expiration of the Tenth Board's term.
Comments